Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0811720220260010001
Korean Journal of Physiology & Pharmacology
2022 Volume.26 No. 1 p.1 ~ p.13
Kidney protective potential of lactoferrin: pharmacological insights and therapeutic advances
Zahan Md. Sarwar

Ahmed Kazi Ahsan
Moni Akhi
Sinopoli Alessandra
Ha Hun-Joo
Uddin Md Jamal
Abstract
Kidney disease is becoming a global public health issue. Acute kidney injury (AKI) and chronic kidney disease (CKD) have serious adverse health outcomes. However, there is no effective therapy to treat these diseases. Lactoferrin (LF), a multi-functional glycoprotein, is protective against various pathophysiological conditions in various disease models. LF shows protective effects against AKI and CKD. LF reduces markers related to inflammation, oxidative stress, apoptosis, and kidney fibrosis, and induces autophagy and mitochondrial biogenesis in the kidney. Although there are no clinical trials of LF to treat kidney disease, several clinical trials and studies on LF-based drug development are ongoing. In this review, we discussed the possible kidney protective mechanisms of LF, as well as the pharmacological and therapeutic advances. The evidence suggests that LF may become a potent pharmacological agent to treat kidney diseases.
KEYWORD
Drug development, Kidney disease, Lactoferrin, Pharmacology, Therapeutics
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed